RxDoctor Payments Data

Lisa Kemp

Family · Arcade, NYNPI 1659880102

Payments from drug & device makers

$1,084in general payments, 2019–2025

Across 69 payments — averaging $15.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$245
  • Lilly USA, LLC$202
  • Novo Nordisk$149
  • GSK$116
  • Boehringer Ingelheim$63
  • Bayer$51
  • plus $257 from 11 others

What the payments were for

  • Food & beverage$1,084100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,084 in reported general payments places this provider in the 70th percentile of 8,883 family providers in New York.

See all family providers in New York

Medicare billing

Part B allowed, 2024
$2,289
Medicare patients
20
Services billed
38

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide42$63,295
EliquisApixaban100$58,314
JardianceEmpagliflozin57$48,050
Trelegy ElliptaFluticasone/Umeclidin/Vilanter52$39,341
TrulicityDulaglutide25$35,211
Synjardy XrEmpagliflozin/Metformin Hcl20$32,158
FarxigaDapagliflozin Propanediol34$24,845
JanuviaSitagliptin Phosphate20$23,903
Janumet XrSitagliptin Phos/Metformin Hcl12$14,646
MyrbetriqMirabegron26$10,243
TrintellixVortioxetine Hydrobromide11$7,880
TradjentaLinagliptin24$6,304
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$6,295
Tiotropium Bromide12$5,491
Atorvastatin Calcium333$3,904

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta$63$86,513101 claims
Novo NordiskOzempic$149$63,29542 claims
PfizerEliquis, Toviaz$17$61,452111 claims
GSKTrelegy Ellipta$116$39,34152 claims
MerckJanuvia, Janumet Xr$17$38,54932 claims
Lilly USA, LLCTrulicity$202$35,21125 claims
AstraZenecaFarxiga$245$24,84534 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$17$7,88011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,883 family providers in New York.

Other family in Arcade

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →